Wertheim P, Slaterus K W, Geelen J L, van der Noordaa J, Wilmink J M
Scand J Urol Nephrol Suppl. 1985;92:5-8.
In a prospective study data were obtained from renal transplant recipients with respect to the incidence and source of infections by CMV and HSV. The incidence of infections with CMV and HSV appeared to be related to the immune suppression regimen used. Especially the high incidence of reinfection with CMV (88.0%) and HSV (81.0) at high prednisolone dosage compared to the lower incidence (CMV 54.5%, HSV 44.1%) at low prednisolone dosage was apparent. Even in very moderate immune suppressed patients infections occurred in at least 40% of them. These infections are known to be potentially harmful to the recipient or to the graft. CMV can be transmitted by the graft in both seronegative and seropositive recipients as demonstrated by restriction enzyme analysis. Therefore CMV related disease has to be considered in all recipients with grafts from seropositive donors. For CMV infection the diagnostic value of serology (CF test) appeared high, while for the diagnosis of HSV infection virus-isolation was of more value.
在一项前瞻性研究中,获取了肾移植受者关于巨细胞病毒(CMV)和单纯疱疹病毒(HSV)感染的发生率及感染源的数据。CMV和HSV感染的发生率似乎与所采用的免疫抑制方案有关。尤其是与低剂量泼尼松龙时较低的再感染发生率(CMV为54.5%,HSV为44.1%)相比,高剂量泼尼松龙时CMV(88.0%)和HSV(81.0%)的再感染发生率明显较高。即使在免疫抑制非常适度的患者中,至少40%的患者也会发生感染。已知这些感染对受者或移植物有潜在危害。如通过限制性内切酶分析所证实的,CMV可在血清阴性和血清阳性受者中通过移植物传播。因此,对于所有接受血清阳性供者移植物的受者,都必须考虑CMV相关疾病。对于CMV感染,血清学(补体结合试验)的诊断价值似乎较高,而对于HSV感染的诊断,病毒分离更有价值。